New Key Statistics Module, Z-Score and F-Score
NAS:EVAX Key Ratios
| Market Cap $ M | 5.46 |
| Enterprise Value $ M | 8.07 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 1.00 |
| Price/Book | 93.00 |
| Price/Sales | 1.52 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 3.00 |
| EPS (TTM) $ | -2.80 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -21.60 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.72 |
| EV-to-EBITDA | -0.72 |
| PEG | -- |
| Shares Outstanding M | 5.87 |
| Net Margin (%) | -347.86 |
| Operating Margin % | -457.42 |
| Pre-tax Margin (%) | -368.80 |
| Quick Ratio | -- |
| Current Ratio | -- |
| ROA % (ttm) | -73.57 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -158.45 |
| Dividend Yield % | -- |
| Altman Z-Score | -12.23 |
EVAX Number of Guru Trades
EVAX Volume of Guru Trades
Gurus Latest Trades with NAS:EVAX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:EVAX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Evaxion Biotech AS Insider Transactions
No Available Data
News about NAS:EVAX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers